Blood test may detect lung cancer in early stages

A simple blood test may be able to detect lung cancer in its early stages, which would represent a promising strategy to improve survival rates, researchers said on Sunday.

Lung cancer survival rates are poor, mainly because the disease, which kills 1.3 million people globally a year, is often diagnosed in advanced stages.

Preliminary findings of a study presented at the annual meeting of the American Society of Clinical Oncology, suggest that a specific genetic profile for lung cancer is present in the blood and can be detected with 88 percent accuracy.

The blood-based lung cancer genetic fingerprint is suitable to identify the disease and predict its occurrence within two years, the study said.

Dr. Thomas Zander of the University Clinic Cologne, who led the research, said more studies are needed to validate the findings.

“Early detection of lung cancer is a major need,” Zander said.

CHICAGO (Reuters)

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

New biomarkers may influence drug design and alternative treatments of cancer, study shows   Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy   Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy   New drug for neuroblastoma shows promise in phase I study   Experimental treatment sends deadly leukemia into remission   Study could reduce unnecessary cancer screening   UA researchers discover component of cinnamon prevents colorectal cancer in mice   Profiling approach to enable right lung cancer treatment match   Fat grafting technique improves results of breast augmentation   Germline TP53 mutations in patients with early-onset colorectal cancer   Clinical trial suggests combination therapy is best for low-grade brain tumors   UW research shows sensor technology may help improve accuracy of clinical breast exams